OMEPRAZOLE EXTENDED-RELEASE CAPSULES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency has awarded DMS PHARMACEUTICAL GROUP INC with contract number SPE2DP26F7433 for the supply of OMEPRAZOLE EXTENDED-RELEASE CAPSULES, identified by NSN 6505013142716, under the broader delivery order SPE2DX25D9900. The award was issued on July 13, 2026, and the total contract value is specified in the associated award documentation. The contractor, identified by CAGE code 1UNB0, is obligated to fulfill requirements for this pharmaceutical item under a federal procurement initiative managed by the Department of Defense. The contract was posted on the DIBBS system on July 23, 2026, and the performance location and point of contact details are not fully specified, though the agency and contracting office are clearly identified as part of the Defense Logistics Agency. The procurement does not indicate a set-aside classification or NAICS code, and all details are accessible via the DIBBS award link.
General Info
Agency
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
(3)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
